News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
52,683 Results
Type
Article (1204)
Company Profile (2)
Press Release (51477)
Section
Business (14743)
Career Advice (121)
Deals (3691)
Drug Delivery (3)
Drug Development (5188)
Employer Resources (8)
FDA (1409)
Job Trends (934)
News (25358)
Policy (1866)
Tag
Academia (131)
Allergies (9)
Alliances (4453)
ALS (9)
Alzheimer's disease (85)
Antibody-drug conjugate (ADC) (12)
Approvals (1407)
Artificial intelligence (29)
Autoimmune disease (1)
Automation (1)
Bankruptcy (19)
Best Places to Work (807)
BIOSECURE Act (1)
Biosimilars (3)
Biotechnology (6)
Bladder cancer (2)
Brain cancer (1)
Breast cancer (13)
Cancer (164)
Cardiovascular disease (6)
Career advice (86)
CAR-T (16)
Cell therapy (48)
Cervical cancer (1)
Clinical research (4359)
Collaboration (63)
Compensation (32)
COVID-19 (115)
CRISPR (3)
C-suite (5)
Cystic fibrosis (14)
Data (166)
Denatured (2)
Depression (2)
Diabetes (12)
Diagnostics (643)
Digital health (1)
Diversity, equity & inclusion (5)
Drug discovery (8)
Drug pricing (4)
Duchenne muscular dystrophy (4)
Earnings (6706)
Editorial (1)
Employer branding (2)
Employer resources (7)
Events (6884)
Executive appointments (26)
FDA (1504)
Featured Employer (1)
Frontotemporal dementia (2)
Funding (50)
Gene editing (9)
Generative AI (3)
Gene therapy (16)
GLP-1 (22)
Government (146)
Guidances (1)
Healthcare (1272)
IgA nephropathy (1)
Immunology and inflammation (3)
Indications (3)
Infectious disease (122)
Inflammatory bowel disease (6)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (7)
Interviews (13)
IPO (1789)
IRA (1)
Job creations (143)
Job search strategy (71)
Layoffs (10)
Legal (363)
Liver cancer (4)
Lung cancer (18)
Lymphoma (17)
Machine learning (1)
Management (2)
Manufacturing (15)
MASH (4)
Medical device (1285)
Medtech (1286)
Mergers & acquisitions (1988)
Metabolic disorders (26)
Multiple sclerosis (13)
NASH (1)
Neurodegenerative disease (2)
Neuropsychiatric disorders (3)
Neuroscience (133)
NextGen: Class of 2025 (507)
Non-profit (205)
Northern California (232)
Obesity (11)
Opinion (11)
Ovarian cancer (4)
Pain (1)
Pancreatic cancer (3)
Parkinson's disease (14)
Patents (21)
Patient recruitment (9)
Peanut (5)
People (2902)
Pharmaceutical (4)
Phase I (1316)
Phase II (1949)
Phase III (1449)
Pipeline (108)
Podcasts (2)
Policy (3)
Postmarket research (121)
Preclinical (569)
Press Release (1)
Prostate cancer (5)
Psychedelics (5)
Radiopharmaceuticals (13)
Rare diseases (29)
Real estate (358)
Recruiting (4)
Regulatory (1465)
Reports (4)
Research institute (105)
Resumes & cover letters (43)
Rett syndrome (2)
Schizophrenia (1)
Series A (7)
Series B (4)
Sickle cell disease (7)
Southern California (158)
Spinal muscular atrophy (6)
Sponsored (1)
Startups (218)
Stomach cancer (1)
Supply chain (2)
United States (1723)
Vaccines (17)
Venture capitalists (1)
Weight loss (3)
Women's health (2)
Date
Last 7 days (52)
Last 30 days (233)
Last 365 days (2901)
2025 (693)
2024 (2974)
2023 (3244)
2022 (4294)
2021 (4713)
2020 (4254)
2019 (3367)
2018 (2729)
2017 (2351)
2016 (2177)
2015 (2900)
2014 (2050)
2013 (1715)
2012 (2118)
2011 (2288)
2010 (1985)
Location
Africa (45)
Alabama (3)
Arizona (6)
Arkansas (2)
Asia (2507)
Australia (546)
California (455)
Canada (235)
China (30)
Colorado (25)
Connecticut (36)
Delaware (22)
Europe (5369)
Florida (61)
Georgia (8)
Idaho (2)
Illinois (44)
India (1)
Indiana (21)
Japan (7)
Kansas (28)
Kentucky (2)
Louisiana (3)
Maine (2)
Maryland (86)
Massachusetts (345)
Michigan (9)
Minnesota (19)
Missouri (6)
Nebraska (2)
Nevada (4)
New Hampshire (16)
New Jersey (152)
New Mexico (2)
New York (96)
North Carolina (24)
North Dakota (2)
Northern California (232)
Ohio (19)
Oregon (3)
Pennsylvania (92)
Rhode Island (1)
South America (50)
Southern California (158)
Tennessee (6)
Texas (101)
Utah (22)
Virginia (5)
Washington D.C. (1)
Washington State (44)
Wisconsin (9)
52,683 Results for "adagene incorporated".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
March 25, 2025
·
17 min read
Press Releases
Adagene to Present at Leerink’s Global Healthcare Conference 2025
March 6, 2025
·
2 min read
Press Releases
Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit
March 13, 2025
·
4 min read
Press Releases
Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer
February 27, 2025
·
5 min read
Biotech Beach
Adagene to Present at Investor Conferences in June
Adagene Inc. today announced its participation in multiple investor conferences in June 2024.
May 22, 2024
·
4 min read
Business
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today reported financial results for the full year 2023 and provided corporate updates.
March 29, 2024
·
22 min read
Press Releases
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
January 27, 2025
·
6 min read
Press Releases
Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
January 21, 2025
·
5 min read
Business
Adagene to Participate in Investor Conferences in September
August 29, 2024
·
2 min read
Biotech Beach
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
Adagene Inc. today announced its participation in the Leerink Partners Global Biopharma Conference 2024, taking place March 11-13 in Miami, Florida.
February 27, 2024
·
1 min read
1 of 5,269
Next
